研究报告 |
|
|
|
|
从大容量噬菌体抗体库中筛选抗Acr蛋白人源单链抗体 |
王晓娜1, 米志强1, 安小平1, 李建彬1, 范华昊1, 张文慧1, 张博1, 黄勇1, 周丽君2, 童贻刚1 |
1. 军事医学科学院微生物流行病研究所 病原微生物生物安全国家重点实验室 北京 100071; 2. 中国人民解放军海军总医院中心研究室 北京 100037 |
|
Screening of Human Anti-α-crystallin Protein of Mycobacterium Tuberculosis scFv from Large Phage Library |
WANG Xiao-na1, MI Zhi-qiang1, AN Xiao-ping1, LI Jian-bin1, FAN Hua-hao1, ZHANG Wen-hui1, ZHANG Bo1, HUANG Yong1, ZHOU Li-jun2, TONG Yi-Gang 1 |
1. State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China; 2. Navy General Hospital, Beijing 100037, China |
引用本文:
王晓娜, 米志强, 安小平, 李建彬, 范华昊, 张文慧, 张博, 黄勇, 周丽君, 童贻刚. 从大容量噬菌体抗体库中筛选抗Acr蛋白人源单链抗体[J]. 中国生物工程杂志, 2012, 32(09): 22-27.
WANG Xiao-na, MI Zhi-qiang, AN Xiao-ping, LI Jian-bin, FAN Hua-hao, ZHANG Wen-hui, ZHANG Bo, HUANG Yong, ZHOU Li-jun, TONG Yi-Gang. Screening of Human Anti-α-crystallin Protein of Mycobacterium Tuberculosis scFv from Large Phage Library. China Biotechnology, 2012, 32(09): 22-27.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I09/22
|
[1] Williams A, Reljic R, Naylor I, et al.Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology, 2004. 111(3): 328-333. [2] Reljic R, Williams A, Ivanyi J, Mucosal immunotherapy of tuberculosis: is there a value in passive IgA? Tuberculosis (Edinb), 2006, 86(3-4): 179-190. [3] López Y, Yero D, Falero-Diaz G, et al. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16 kDa protein in a model of progressive pulmonary infection. International Journal of Medical Microbiology, 2009, 299(6): 447-452. [4] Reljic R, Clark S, Williams A, et al. Intranasal IFNγ extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection. Clinical & Experimental Immunology, 2006,143(3): 467-473. [5] Buccheri S, Reljic R, Caccamo N, et al.IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice. European journal of immunology, 2007, 37(3): 729-737. [6] Buccheri S, Reljic R, Caccamo N, et al. Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. Tuberculosis, 2009, 89(1): 91-94. [7] Grosset, J.Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrobial agents and chemotherapy, 2003, 47(3): 833-836. [8] Nunn P, Williams B, Floyd K, et al.Tuberculosis control in the era of HIV. Nature Reviews Immunology, 2005, 5(10): 819-826. [9] Teitelbaum R, Glatman-Freedman A, Chen B, et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proceedings of the National Academy of Sciences, 1998, 95(26): 15688. [10] Hamasur B, Haile M, Pawlowski A,et al.A mycobacterial lipoarabinomannan specific monoclonal antibody and its F (ab') 2 fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clinical & Experimental Immunology, 2004, 138(1): 30-38. [11] Pethe K, Alonso S, Biet F, et al.The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature, 2001, 412(6843): 190-194. [12] Chambers M A, Gavier-Widén D, Glyn Hewinson R. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge. FEMS Immunology & Medical Microbiology, 2004, 41(2): 93-100. [13] Roy E, Stavropoulos E, Brennan J, et al. Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice. Infect Immun, 2005, 73(9):. 6101-6109. [14] Olivares N, Puig A, Aguilar D, et al.Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis. Tuberculosis (Edinb), 2009, 89(3): 218-220. [15] Guirado E, Amat I, Gil O, et al.Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect, 2006, 8(5): 1252-1259. [16] 张廷芬,师长宏. Hsp16. 3 的生物学特性及其在结核病研究中的应用. 中华结核和呼吸杂志, 2007, 30(6): 456-458. Zhang T F, Shi C H. Biology characteristics of Hsp16.3 and its application in tuberculosis. Chin J Tuberc Respri Dis, 2007,30(6): 456-458. [17] Boon C, Li R, Qi R, et al. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J Bacteriol, 2001, 183(8): 2672-2676. [18] Cunningham A F, Spreadbury C L. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton α-crystallin homolog. Journal of bacteriology, 1998, 180(4): 801-808. [19] Lim A, Eleuterio M, Hutter B et al. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J Bacteriol, 1999, 181(7): 2252-2256. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|